Journal of Yeungnam Medical Science

Yeungnam University College of Medicine, Yeungnam University Institute Medical Science (영남대 의대 학술지 편집위원회)
권호 표지
DOI QR코드

DOI QR Code

Colchicine for steroid-resistant recurrent pericarditis in a child

  • Shin, Ju Hee (Department of Pediatrics, Keimyung University School of Medicine) ;
  • Lee, Dong Hyun (Department of Pediatrics, Keimyung University School of Medicine) ;
  • Choi, Hee Joung (Department of Pediatrics, Keimyung University School of Medicine)
  • Received : 2017.12.19
  • Accepted : 2018.01.17
  • Published : 2018.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Recurrent pericarditis is rare in children and is considered idiopathic in most cases. Its course is chronic, and preventing recurrences is important for the patient's quality of life. Although a treatment strategy in pediatric recurrent pericarditis has not yet been established, non-steroidal anti-inflammatory drugs (NSAIDs) are the most common treatment for management of this condition, followed by corticosteroids, colchicine, immunosuppressive agents, immunoglobulins, and interleukin-$1{\beta}$ receptor antagonists (e.g. anakinra). Herein, we report a case of recurrent pericarditis with pericardial effusion in a 5-year-old child who presented with fever and epigastric pain. He responded poorly to NSAIDs and corticosteroid therapy, but was successfully treated with colchicine.

Keywords

References

  1. LeWinter MM. Clinical practice. Acute pericarditis. N Engl J Med 2014;371:2410-6. https://doi.org/10.1056/NEJMcp1404070
  2. Imazio M, Gribaudo E, Gaita F. Recurrent pericarditis. Prog Cardiovasc Dis 2017;59:360-8. https://doi.org/10.1016/j.pcad.2016.10.001
  3. Shakti D, Hehn R, Gauvreau K, Sundel RP, Newburger JW. Idiopathic pericarditis and pericardial effusion in children: contemporary epidemiology and management. J Am Heart Assoc 2014;3:e001483.
  4. Gaspari S, Marsili M, Imazio M, Brucato A, Di Blasi Lo Cuccio C, Chiarelli F, et al. New insights in the pathogenesis and therapy of idiopathic recurrent pericarditis in children. Clin Exp Rheumatol 2013;31:788-94.
  5. Imazio M, Spodick DH, Brucato A, Trinchero R, Adler Y. Controversial issues in the management of pericardial diseases. Circulation 2010;121:916-28. https://doi.org/10.1161/CIRCULATIONAHA.108.844753
  6. Imazio M, Brucato A, Pluymaekers N, Breda L, Calabri G, Cantarini L, et al. Recurrent pericarditis in children and adolescents: a multicentre cohort study. J Cardiovasc Med (Hagerstown) 2016;17:707-12. https://doi.org/10.2459/JCM.0000000000000300
  7. Raatikka M, Pelkonen PM, Karjalainen J, Jokinen EV. Recurrent pericarditis in children and adolescents: report of 15 cases. J Am Coll Cardiol 2003;42:759-64. https://doi.org/10.1016/S0735-1097(03)00778-2
  8. Adler Y, Charron P, Imazio M, Badano L, Baron-Esquivias G, Bogaert J, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases. Eur Heart J 2015;36:2921-64. https://doi.org/10.1093/eurheartj/ehv318
  9. Alabed S, Perez-Gaxiola G, Burls A. Colchicine for children with pericarditis: systematic review of clinical studies. Arch Dis Child 2016;101:953-6. https://doi.org/10.1136/archdischild-2015-310287
  10. Imazio M, Adler Y. Treatment with aspirin, NSAID, corticosteroids, and colchicine in acute and recurrent pericarditis. Heart Fail Rev 2013;18:355-60. https://doi.org/10.1007/s10741-012-9328-9
  11. Imazio M, Brucato A, Cumetti D, Brambilla G, Demichelis B, Ferro S, et al. Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation 2008;118:667-71. https://doi.org/10.1161/CIRCULATIONAHA.107.761064
  12. Artom G, Koren-Morag N, Spodick DH, Brucato A, Guindo J, Bayes-de-Luna A, et al. Pretreatment with corticosteroids attenuates the efficacy of colchicine in preventing recurrent pericarditis: a multi-centre all-case analysis. Eur Heart J 2005;26:723-7. https://doi.org/10.1093/eurheartj/ehi197
  13. del Fresno MR, Peralta JE, Granados MA, Enriquez E, Dominguez-Pinilla N, de Inocencio J. Intravenous immunoglobulin therapy for refractory recurrent pericarditis. Pediatrics 2014;134:e1441-6. https://doi.org/10.1542/peds.2013-3900
  14. Scardapane A, Brucato A, Chiarelli F, Breda L. Efficacy of an interleukin-$1{\beta}$ receptor antagonist (anakinra) in idiopathic recurrent pericarditis. Pediatr Cardiol 2013;34:1989-91. https://doi.org/10.1007/s00246-012-0532-0